MyFinsight
Home
Blog
About
Contact
Download
Download image
Comprehensive loss
-$183,527K
Unrealized gain on
investments
$330K
Net loss
-$183,793K
Gain/(loss) on foreign
currency translation
-$64K
Loss from operations
-$166,309K
Total other expense,
net
-$17,484K
Interest income
$10,960K
Total operating
expenses
$166,309K
Change in fair value of
2022 usd financing...
$22,831K
Interest expense
$5,482K
Foreign exchange loss,
net
-$131K
Research and development
$117,665K
General and
administrative
$48,644K
Back
Back
Income Statement
source: myfinsight.com
Definium Therapeutics, Inc. (DFTX)
Definium Therapeutics, Inc. (DFTX)